NewLink Genetics Corporation Stock Price and Value Analysis

Should you buy NewLink Genetics Corporation stock? (NasdaqGM:NLNK). Let's see how it does in our automated value investing analysis system.

NLNK Free Cash Flow Trend

Free Cash Flow trendline for NLNK
Free Cash Flow trendline for NewLink Genetics Corporation

Hmm, we can't give any reliable projection for NewLink Genetics Corporation's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has wild ups and downs.
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

Inside the NLNK Numbers

NLNK Price
(NewLink Genetics Corporation stock price per share)
PE Ratio versus Sector 73% lower than other Healthcare stocks
PE Ratio versus Industry 90% lower than other Biotechnology stocks
Cash Yield -41.40%
Free Cash Flow Jitter 262%

Is NewLink Genetics Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy NewLink Genetics Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy NLNK Stock?

Does NewLink Genetics Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.